Centrum Medyczne Damiana Holding Sp. z o.o. — Clinical Trial Site

8 Registered trials

2 Currently recruiting

Organisation

Centrum Medyczne Damiana Holding Sp. z o.o.

Location

Szczecin, Poland

Identifier

ORG-100042041

Address

Ul. Walbrzyska 46, 02-739, Poland

Departments

Dom Lekarski - Ambulatorium Struga
DOM LEKARSKI - AMBULATORIUM STRUGA
MICS Centrum Medyczne Damiana, Wałbrzyska
N/A

Clinical trials at this site (8)

Search interface

A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC Recruiting

2025-522867-13-00 Non Small Cell Lung Cancer 4 2026-04-27
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting

2023-504724-25-00 Primary Myelofibrosis 5 2024-10-16
A trial to find out how safe REGN7075 is and how well it works in combination with cemiplimab for participants with advanced cancers Ended

2022-501234-37-00 Solid Tumours 7 2024-05-07
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants with Systemic Lupus Er… Ended

2022-502632-39-00 Systemic Lupus Erythematosus (SLE) 1 2023-10-11
Study of DS-1062a with or without Pembrolizumab in Advanced or Metastatic Non-small Cell Lung Cancer without Actionable Genomic Alterations Ended

2023-507933-12-00 Advanced or Metastatic Non-small Cell Lung Cancer (NSCL 5 2022-08-18
Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer Ended

2023-509169-19-00 Advanced ALK positive non-small cell lung cancer 5 2017-07-11
C4951004 - BHV3000-406: A Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute … Ended

2024-513269-37-00 Migraine attacks with or without aura 6 2023-03-14
C4951012 - BHV3000-407: A Phase 4, Randomized, Double-blind, Placebo controlled Study to Evaluate the Efficacy and Tolerability of Rimegepan… Ended

2024-513270-21-00 migraine headaches with or without aura 6 2023-03-14